Unilever (UL, $50.39) won't raise bid beyond £50 billion for GSK's healthcare division
Unilever shares climbed higher on Wednesday, after the consumer goods company announced that it won't increase its offer for the consumer healthcare division of GlaxoSmithKline above £50 billion.
GSK's health products business owns brands such as Panadol, Sensodyne toothpaste, and Centrum vitamins.
According to GSK, Unilever's bid valued at around $68 billion has "fundamentally undervalued" the division. GSK was reportedly wants an offer in the region of £60 billion following the addition of brands from Novartis in 2015 and Pfizer in 2019.
"The acquisition would create scale and a growth platform for the combined portfolio in the US, China and India, with further opportunities in other emerging markets," Unilever said, emphasizing on synergies in the oral care and vitamin supplements business.
UL in upward trend: price may ascend as a result of having broken its lower Bollinger Band on May 19, 2022
UL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 45 cases where UL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 51%.
Current price $43.82 crossed the support line at $44.08 and is trading between $44.08 support and $42.71 support lines. Throughout the month of 04/26/22 - 05/26/22, the price experienced a -3% Downtrend, while the week of 05/19/22 - 05/26/22 shows a +2% Uptrend.
The Stochastic Indicator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 23 of 62 cases where UL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 37%.
Following a +1.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where UL advanced for three days, in 106 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 34%.
The Momentum Indicator moved below the 0 level on May 24, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on UL as a result. In 29 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 33%.
The Moving Average Convergence Divergence Histogram (MACD) for UL turned negative on May 18, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 20 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 39%.
UL moved below its 50-day Moving Average on May 18, 2022 date and that indicates a change from an upward trend to a downward trend.
The 10-day Moving Average for UL crossed bearishly below the 50-day moving average on May 17, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 33%.
The Aroon Indicator for UL entered a downward trend on April 28, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Tickeron has a positive outlook on this ticker and predicts a further increase by more than 4.00% within the next month with a likelihood of 55%. During the last month, the daily ratio of advancing to declining volumes was 1 to 1.03.
The Tickeron Seasonality Score of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.094) is normal, around the industry mean (23.152). P/E Ratio (17.606) is within average values for comparable stocks, (175.479). Projected Growth (PEG Ratio) (2.515) is also within normal values, averaging (3.492). UL has a moderately high Dividend Yield (0.044) as compared to the industry average of (0.026). P/S Ratio (2.032) is also within normal values, averaging (61.519).
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. UL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 97 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
The average market capitalization across the Household/Personal Care Industry is 18.5B. The market cap for tickers in the group ranges from 84.3K to 348.4B. PG holds the highest valuation in this group at 348.4B. The lowest valued company is BMXC at 84.3K.
The average weekly price growth across all stocks in the Household/Personal Care Industry was 0.37%. For the same Industry, the average monthly price growth was -5.35%, and the average quarterly price growth was -17.52%. SNBH experienced the highest price growth at 45.71%, while LIOPY experienced the biggest fall at -56.44%.
- 3/5/22 8:15 AM: Unilever (UL, $45.68) was a top loser this week, declining -9.63%
The average weekly volume growth across all stocks in the Household/Personal Care Industry was -15.44%. For the same stocks of the Industry, the average monthly volume growth was -26.25% and the average quarterly volume growth was 4.44%
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Stocks in the group have a Negative Outlook today, backed by the MA200MA50 Indicator. Tickeron has a negative outlook on this group and predicts a further decline by more than 4.00% within the next month with a likelihood of 31%. During the last month, the daily ratio of advancing to declining volumes was 1 to 1.26.
11 stocks in the group of tickers confirmed the negative outlook based on the 15 indicator with average odds of 66%.
The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).
The average market capitalization across the group is 20.6B. The market cap for tickers in the group ranges from 0 to 348.4B. PG holds the highest valuation in this group at 348.4B. The lowest valued company is SNST at 0.
The average weekly price growth across all stocks in the group was 3.33%. For the same group, the average monthly price growth was -4.37%, and the average quarterly price growth was -20.33%. SNBH experienced the highest price growth at 45.71%, while JGLCF experienced the biggest fall at -13.16%.
- 5/25/22 7:32 AM: Sentient Brands Holdings (SNBH, $0.05) was a top weekly gainer, with a +27.5% jump
- 5/20/22 5:28 AM: Kimberly-Clark (KMB, $129.05) was a top loser this week, declining -7.56%
- 5/20/22 5:28 AM: Hims & Hers Health (HIMS, $3.55) was a top weekly gainer, with a +10.94% jump
The average weekly volume growth across all stocks in the group was 140.06%. For the same stocks of the group, the average monthly volume growth was 745.49% and the average quarterly volume growth was 559.26%
- 5/4/22 8:21 AM: The volume for Henkel AG and Co KGAA stock increased for one day, resulting in a record-breaking daily growth of 824% of the 65-Day Volume Moving Average
- 4/30/22 5:53 AM: The volume for NuSkin Enterprises stock increased for one day, resulting in a record-breaking daily growth of 433% of the 65-Day Volume Moving Average
- 4/30/22 5:53 AM: The volume for Henkel AG and Co KGAA stock increased for one day, resulting in a record-breaking daily growth of 276% of the 65-Day Volume Moving Average
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows